Black Rock Inc. Omega Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 363,953 shares of OMGA stock, worth $7,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares

363,953

Previous 1,415,428 74.29%

Holding current value

$7,279

Previous $5.17 Million 85.42%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.86 - $3.2 $1.96 Million - $3.36 Million	-1,051,475 Reduced 74.29%	363,953 $753,000
Q1 2024 May 10, 2024	BUY	$2.73 - $5.32 $90,494 - $176,347	33,148 Added 2.4%	1,415,428 $5.17 Million
Q4 2023 Feb 13, 2024	SELL	$1.35 - $3.21 $199,339 - $473,985	-147,659 Reduced 9.65%	1,382,280 $4.16 Million
Q3 2023 Nov 13, 2023	SELL	$2.15 - $5.68 $171,456 - $452,962	-79,747 Reduced 4.95%	1,529,939 $3.29 Million
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $5.95 Million - $10.3 Million	1,062,612 Added 194.24%	1,609,686 $9.01 Million
Q1 2023 May 12, 2023	SELL	$4.81 - $10.95 $128,730 - $293,054	-26,763 Reduced 4.66%	547,074 $3.3 Million
Q4 2022 Feb 13, 2023	SELL	$4.22 - $7.05 $351,462 - $587,159	-83,285 Reduced 12.67%	573,837 $3.28 Million
Q3 2022 Nov 14, 2022	SELL	$3.63 - $6.65 $142,521 - $261,092	-39,262 Reduced 5.64%	657,122 $3.56 Million
Q2 2022 Aug 12, 2022	SELL	$2.01 - $7.19 $2.43 Million - $8.69 Million	-1,209,004 Reduced 63.45%	696,384 $2.65 Million
Q1 2022 May 12, 2022	BUY	$6.24 - $14.04 $5.45 Million - $12.3 Million	873,823 Added 84.71%	1,905,388 $11.9 Million
Q4 2021 Feb 10, 2022	BUY	$11.33 - $29.38 $831,497 - $2.16 Million	73,389 Added 7.66%	1,031,565 $11.7 Million
Q3 2021 Nov 09, 2021	BUY	$16.0 - $22.51 $15.3 Million - $21.6 Million	958,176 New	958,176 $18.1 Million

Others Institutions Holding OMGA

# of Institutions

Shares Held

1.51M

Call Options Held

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $957K
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account